(0.13%) 5 138.00 points
(0.09%) 38 475 points
(0.21%) 17 883 points
(-0.25%) $83.64
(1.72%) $1.956
(0.13%) $2 350.30
(0.46%) $27.66
(1.61%) $936.90
(-0.18%) $0.933
(-0.28%) $10.99
(-0.29%) $0.798
(1.17%) $92.95
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments...
Stats | |
---|---|
本日の出来高 | 3.00 |
平均出来高 | 301.00 |
時価総額 | 18.13B |
EPS | €0 ( 2024-04-22 ) |
次の収益日 | ( €0 ) 2024-05-01 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -16.68 |
ATR14 | €0 (0.00%) |
Illumina Inc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Illumina Inc 財務諸表
Annual | 2023 |
収益: | €4.50B |
総利益: | €2.74B (60.92 %) |
EPS: | €-7.35 |
FY | 2023 |
収益: | €4.50B |
総利益: | €2.74B (60.92 %) |
EPS: | €-7.35 |
FY | 2022 |
収益: | €4.58B |
総利益: | €2.97B (64.83 %) |
EPS: | €-28.05 |
FY | 2021 |
収益: | €4.53B |
総利益: | €3.15B (69.69 %) |
EPS: | €5.07 |
Financial Reports:
No articles found.
Illumina Inc
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。